■ 学術雑誌
|
原著
|
|
1.
|
HARAGUCHI Yuji†, MATSUURA Katsuhisa, KAGAWA Yuki, HASEGAWA Akiyuki, KUBO Hirotsugu, SHIMIZU Tatsuya*：
Rapid creation system of morphologically and functionally communicative three-dimensional cell-dense tissue by centrifugation.
Biotechnology progress
34
(6)
：1447-1453
, 2018.12
|
|
2.
|
MASUDA Shinako†, MATSUURA Katsuhisa*, SHIMIZU Tatsuya：
Preparation of iPS cell-derived CD31+ endothelial cells using three-dimensional suspension culture.
Regenerative Therapy
9
：*1-9
, 2018.12
|
|
3.
|
MATSUURA Katsuhisa†*, HAGIWARA Nobuhisa, SHIMIZU Tatsuya：
iPS cell elimination in a cell sheet by methionine-free and 42 °C condition for tumor prevention.
Tissue Engineering Part C: Methods
24
(10)
：605-615
, 2018.10
|
|
4.
|
MASUDA Shinako†, MATSUURA Katsuhisa*, SHIMIZU Tatsuya：
Inhibition of LYPD1 is critical for endothelial network formation in bioengineered tissue with human cardiac fibroblasts.
Biomaterials
166
：109-121
, 2018.6
|
|
5.
|
Kazutaka Kitamura, Kayoko Sato, Motoji Sawabe, Masayuki Yoshida, Nobuhisa Hagiwara：
PSGL-1 expressing CD4 T cells contribute plaque instability in acute coronary syndrome.
Circulation Journal
：1-8
, 2018.6
|
|
6.
|
Nohara Atsushi, Ohmura Hirotoshi, Okazaki Hiroaki, Ogura Masatsune, Kitagawa Kazuo, Koseki Masahiro, Sato Kayoko, Tsukamoto Kazuhisa, Yamashita Shizuya,：
Statement for Appropriate Clinical Use of PCSK9 Inhibitors.
Journal of atherosclerosis and thrombosis
25
：1-4
, 2018.6
|
|
7.
|
逸見 隆太, 江島 浩一郎, 柳下 大悟, 岩波 裕史, 樋口 諭, 萩原 誠久, 庄田 守男：
High-Resolution Mappingによる右房切開後Reentrant ATの電気生理学的新知見.
臨床心臓電気生理
41
：167-174
, 2018.5
|
|
総説及び解説
|
|
1.
|
MATSUURA Katsuhisa†：
Toward the Development of Novel Therapy for Hypertrophic Cardiomyopathy.
International Heart Journal
59
(5)
：914-916
, 2018.9
|
|
2.
|
松浦勝久†：
心不全治療のための補助循環を目指した移植用心筋組織開発.
循環器専門医
27
：9-18
, 2018.8
|
|
症例報告
|
|
1.
|
Yuji Murakawa, Teiichi Yamane, Masahiko Goya, Koichi Inoue, Shigeto Naito, Koichiro Kumagai,
Yasushi Miyauchi, Norishige Morita, Akihiko Nogami, Morio Shoda, Ken Okumura, Kenzo Hirao：
Influence of substrate modification in catheter ablation of atrial fibrillation on the incidence of acute complications:Analysis of 10 795 procedures in J-CARAF Study 2011-2016.
Journal of Arrhythmia
：10.1002/joa3.12081-10.1002/joa3.12081
, 2018.8
|
|
2.
|
諏訪邦明, 庄田守男, 柳下大悟, 江島浩一郎, 岩波裕史, 樋口諭, 山賀彩花, 中岡隆志, 佐倉宏, 布田伸一, 萩原誠久：
リードレスペースメーカの良い適応と考えられた徐脈性不整脈疾患の症例.
適応医学
：14-23
, 2018.7
|
|
3.
|
Gold Michael R, Auricchio Angelo, Leclercq Christophe, Lowy Jonathan, Rials Seth J, Shoda Morio, Tomassoni Gery, Yong Patrick, Wold Nicholas, Ellenbogen Kenneth A：
The rationale and design of the SMART CRT trial.
Pacing and clinical electrophysiology : PACE
：10.1111/pace.13459
, 2018.7
|
|
その他
|
|
1.
|
Morioka Yuta, Arashi Hiroyuki, Otsuki Hisao, Yamaguchi Junichi, Hagiwara Nobuhisa：
Relationship between instantaneous wave-free ratio and fractional flow reserve in patients receiving hemodialysis.
Cardiovascular intervention and therapeutics
33
(3)
：256-263
, 2018.7
|
|
2.
|
Suzuki Atsushi, Shiga Tsuyoshi, Yagishita Daigo, Yagishita-Tagawa Yoshimi, Arai Kotaro, Iwanami Yuji, Ejima Koichiro, Ashihara Kyomi, Shoda Morio, Hagiwara Nobuhisa：
Narrowing filtered QRS duration on signal-averaged electrocardiogram predicts outcomes in cardiac resynchronization therapy patients with nonischemic heart failure.
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
23
(3)
：e12523
, 2018.5
|
|
3.
|
Kubota Yoshiaki, Tay Wan Ting, Asai Kuniya, Murai Koji, Nakajima Ikutaro, Hagiwara Nobuhisa, Ikeda Takanori, Kurita Takashi, Teng Tiew-Hwa Katherine, Anand Inder, Lam Carolyn S P, Shimizu Wataru,：
Chronic obstructive pulmonary disease and β-blocker treatment in Asian patients with heart failure.
ESC heart failure
5
(2)
：297-305
, 2018.4
|
|
4.
|
Kogure Tomohito, Jujo Kentaro, Hamada Kazuyuki, Saito Katsumi, Hagiwara Nobuhisa：
Good response to tolvaptan shortens hospitalization in patients with congestive heart failure.
Heart and vessels
33
(4)
：374-383
, 2018.4
|
|
ページの先頭へ
|
|
■ 学会発表
|
1.
|
Matsuuta Katsuhisa：
Development of scalable 3D suspension bioreactor system for human iPS cell expansion and differentiation.
The 31st Annual and International Meeting of the Japanese Association for Animal Cell Technology (JAACT2018 Tsukuba),
Tsukuba, Japan,
2018/11
|
|
2.
|
◎Matsuura Katsuhisa：
Development of human cardiac tissue from iPS cells for transplantation.
4th Stem Cells and Cellular Therapy Conference,
Riyadh, Saudi Arabia,
2018/10
|
|
3.
|
◎Matsuura Katsuhisa：
Identification of the tissue specific phenotypes of heart-derived fibroblasts for tissue engineering.
4th Stem Cells and Cellular Therapy Conference,
Riyadh, Saudi Arabia,
2018/10
|
|
4.
|
◎Matsuura Katsuhisa：
Identification of the tissue specific phenotypes of heart-derived fibroblasts for tissue engineering and further understanding "Heart".
TERMIS world congress 2018,
Kyoto,
2018/09
|
|
5.
|
SEKIGUCHI HARUKI, Abe Takuro, ◎Yamamoto Eri, Koike Toshiharu, Sakai Akiko, SATO Kayoko, Nobuhisa Hagiwara：
Underdiagnosis and non-treatment of heterozygous familial hypercholesterolemia in association with cardiovascular disease.
ESC Congress 2018,
München, Germaney,
2018/08
|
|
6.
|
SEKIGUCHI HARUKI, Yoshiura Asami,◎Fukushima Tatsuya, Suzuki Keisuke, Ogiso Masataka, Watanabe Erisa, ARASHI Hiroyuki, YAMAGUCHIJUNICHI, HIROSHIOGAWA, NobuhisaHagiwara：
Simple risk score for predicting secondary cardiovascular events in ACS patients undergoing contemporary aggressive lipid-lowering management for dyslipidaemia: a sub-analysis of the HIJ-PROPER study.
ESC congress 2018,
München, Germaney,
2018/08
|
|
7.
|
Haruki Sekiguchi, ◎Asami Yoshimura, Tatsuya Fukushima, Keisuke SUzuki, Masataka Ogiso, Erisa Watanabe, ARASHI Hiroyuki, YAMAGUCHI JUNICHI, HIROSHI OGAWA, Nobuhisa Hagiwara：
Comparison of risk factors for cardiovascular outcomes between patients with and without diabetes: results from the HIJ-PROPER Study.
ESC Congress 2018,
München, Germany,
2018/08
|
|
8.
|
◎Matsuura Katsuhisa, Shinako Masuda, SHIMIZU Tatsuya：
Human cardiac fibroblasts have angiogenic inhibitory phenotypes through their expressing LYPD1 in vitro.
BCVS 2018,
San Antonio, USA,
2018/07
|
|
9.
|
◎SEKIGUCHI HARUKI, Yamamoto Eri, Abe Takuro, Koike Toshiharu, SATO Kayoko, Nobuhisa Hagiwara：
Insight into Polygenetic Abnormalities in Japanese Heterozygous Familial Hypercholesterolemia.
XVIIIIth International Symposium on Atherosclerosis,
Toronto, Canada,
2018/06
|
|
10.
|
◎SEKIGUCHI HARUKI, Koike Toshiharu, Yamamoto Eri, Abe Takuro, Sakai Akiko, SATO Kayoko, Nobuhisa Hagiwara：
Proprotein Convertase Subtilisin/kexin Type 9 (PCSK-9) inhibitors Improve Lipid Profile and Vascular Atherosclerotic Plaque in Familial Hypercholesterolemia.
XVIIIIth International Symposium on Atherosclerosis,
Toronto, Canada,
2018/06
|
|
11.
|
◎SEKIGUCHI HARUKI, Kawamoto Takanori, Taukamoto Kei, Suzuki Atsushi, sekiguchi Naoki, Fukushima Kenji, Nagao Michinobu, NISHIMURA Katsuji, Tsuyoshi Shiga, Nobuhisa Hagiwara◎：
The impact of Brain atrophy in the young patients with severe heart failure.
23rd Annual Meeting of the International Society of Cardiovascular Pharmacotherapy (ISCP2018),
Kyoto, Japan,
2018/05
|
|
12.
|
◎HARUKI SEKIGUCHI, MORITA Sae, SERIZAWA Naoki, Mayumi Suzuki, ARAI Kotaro, Tsuyoshi Shiga, Nobuhisa Hagiwara：
Optimized settings for adaptive servo ventilation in patients with severe heart failure based on the echocardiogram.
Asian Pacific Society of Cardiology Congress 2018 (APSC 2018),
Taipei, TAIWAN,
2018/05
|
|
13.
|
◎HARUKI SEKIGUCHI, Takanori Kawamoto, Kei Tsukamoto, SuzukiAtsushi, Naoki Sekiguchi, Kenji Fukushima, Michinobu Nagao, NISHIMURA Katsuji, Tsuyoshi Shiga, Nobuhisa Hagiwara：
The impact of Brain atrophy in the young patients with severe heart failure.
Asian Pacific Society of Cardiology Congress 2018 (APSC 2018),
Taipei, TAIWAN,
2018/05
|
|
14.
|
◎松浦勝久：
組織工学を用いた心筋症・心不全の病態解明への挑戦.
第22回日本心不全学会学術集会,
東京,
2018/10
|
|
15.
|
◎遠藤奈津美, 服部英敏, 菊池規子, 石田英樹, 新浪博, 布田伸一：
60歳代心臓移植患者の移植後ケアに社会資源を必要とした一例.
第54回日本移植学会総会,
東京,
2018/10
|
|
16.
|
◎Eri Yamamoto, Kayoko Sato, Haruki Sekiguchi,Yasutaka Imamura, Hidekimi Nomura, Akiko Sakai,Nobuhisa Hagiwara：
Aortic Vale calcification and coronary atherosclerosis in familial hypercholesterolemia patients.
The 2nd JCS Council Forum Basic CardioVascular Reseach,
Nara, Japan,
2018/09
|
|
17.
|
◎Hidekimi Nomura, Kayoko Sato, Haruki Sekiguchi, Eri Yamamoto, Takuro Abe, Yoshinori Seko, Nobuhisa Hagiwara：
The role of ORAIP for the coronary artery plaque instability in Familial Hypercholesterolemia.
The 2nd JCS Council Forum on Basic CardioVascular Research,
Nara, Japan,
2018/09
|
|
18.
|
松浦 純也、関口 治樹、 阿部 拓朗、 小池 俊晴、 木村 眞樹子、 坂井 晶子、 佐藤 加代子、 萩原 誠久：
家族性高コレステロール血症患者における動脈硬化進展の性差について.
第66回 日本心臓病学会学術集会,
大阪,
2018/09
|
|
19.
|
◎木村 眞樹子、関口 治樹、 福島 立也、 菊池 規子、 鈴木 敦、 志賀 剛、 萩原 誠久：
慢性心不全に対する塩分制限：日本人に対する塩分制限6gと3ｇの比較（ランダム化前向き介入試験）.
第66回 日本心臓病学会学術集会,
大阪,
2018/09
|
|
20.
|
◎松浦勝久：
Development of pulsatile human cardiac tissue for heart failure treatment and epicardial transplantation approach for synchronized pulsation with host myocardium and arrhythmia prevention.
第65回日本不整脈心電学会学術大会,
東京,
2018/07
|
|
21.
|
坂井晶子, 佐藤加代子, 山本恵理, ◎関口治樹, 坂井修二, 萩原誠久：
心血管病変既往の有無による家族性高コレステロール血症と大動脈弁石灰化、脂質プロファイルとの関連性.
第50会 日本動脈硬化学会・学術集会,
大阪,
2018/07
|
|
22.
|
◎関口治樹, 阿部拓朗, 山本恵理, 坂井晶子, 佐藤加代子, 萩原誠久：
心血管病変既往による家族性高コレステロール血症と原発性脂質異常症患者の脂質プロファイル、血管内皮機能および冠動脈プラークの違い.
第50回 日本動脈硬化学会総会・学術集会,
大阪,
2018/07
|
|
23.
|
関口治樹, ◎福島博, 鈴木敦, 新井光太郎, 芦原京美, 福島賢慈, 長尾充展, 宇都健太, 村崎かがり, 萩原誠久：
当院でのCalcified Amorphous Tumor 症例とmulti-detector computed tomographyを用いた定量解析.
若手医師のための循環器内科セミナー2018,
東京,
2018/06
|
|
10件表示
|
|
全件表示(23件)
|
|
ページの先頭へ
|
|
